ScoreWhy is Beta Drugs Ltd ?
1
With ROCE of 21.9, it has a Expensive valuation with a 4.8 Enterprise value to Capital Employed
- Over the past year, while the stock has generated a return of -100.00%, its profits have fallen by -9%
2
Below par performance in long term as well as near term
- Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Beta Drugs Ltd for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Beta Drugs Ltd
-32.46%
-0.79
40.96%
Sensex
-8.84%
-0.67
13.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
31.90%
EBIT Growth (5y)
34.42%
EBIT to Interest (avg)
13.38
Debt to EBITDA (avg)
1.92
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
1.02
Tax Ratio
23.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.20%
ROCE (avg)
26.77%
ROE (avg)
55.34%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
5.20
EV to EBIT
22.15
EV to EBITDA
17.13
EV to Capital Employed
4.84
EV to Sales
3.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.86%
ROE (Latest)
16.95%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
PBDIT(Q)
Highest at Rs 9.76 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 17.96%
PBT LESS OI(Q)
Highest at Rs 4.14 cr.
PAT(Q)
Highest at Rs 5.33 cr.
EPS(Q)
Highest at Rs 5.26
-1What is not working for the Company
NON-OPERATING INCOME(Q)
is 41.36 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Beta Drugs Ltd
Profit After Tax (PAT) - Quarterly
At Rs 5.33 cr has Grown at 112.1%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 4.14 cr has Grown at 67.61%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 9.76 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 17.96%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 4.14 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 5.33 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 5.26
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Beta Drugs Ltd
Non Operating Income - Quarterly
is 41.36 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
